Literature DB >> 8792309

Case report: fibrolamellar hepatocellular carcinoma in a Japanese woman: a case report and review of Japanese cases.

H Hoshino1, N Katada, D Nishimura, J Imada, K Morita, N Yoshida, H Sano, K Okamoto, K Kato.   

Abstract

Fibrolamellar hepatocellular carcinoma (FLHCC) is an entity distinct from ordinary hepatocellular carcinoma and is very rare in Oriental countries. We present here a Japanese case of FLHCC in a 25 year old woman, and review Japanese cases of FLHCC. The patient had mild abdominal pain when the hepatic tumour was revealed by ultrasonography. Hepatitis B surface antigen (HBsAg) and anti-hepatitis C antibody were negative and serum alpha-fetoprotein (AFP) was within the normal limit. Ultrasound-guided fine needle biopsy was performed and the tumour was histologically diagnosed as FLHCC. A right lobectomy of the liver was then performed. Macroscopically, the tumour (10 x 10 x 8 cm) was circumscribed, rather hard and yellowish white. Microscopically, neoplastic hepatocytes were polygonal and large with eosinophilic cytoplasm, which contained pale bodies. A number of fibrous stroma were arranged in thin parallel bands. Consequently, the case was diagnosed as FLHCC. In Japan, approximately 18,000 people die of ordinary hepatocellular carcinoma annually, while only nine cases (including the present case; six males, three females) of FLHCC in Japanese subjects have been reported previously. The mean age of the Japanese cases of FLHCC is 20.9 years old. One case with positive HBsAg, liver cirrhosis and high level of AFP was observed of nine cases. The nature of FLHCC in Japanese subjects may not be significantly different from that in Caucasians, except for male predominance.

Entities:  

Mesh:

Year:  1996        PMID: 8792309     DOI: 10.1111/j.1440-1746.1996.tb01701.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  4 in total

Review 1.  Typical fibrolamellar hepatocellular carcinoma in a Japanese boy: report of a case.

Authors:  Masanori Matsuda; Hidetake Amemiya; Hiromichi Kawaida; Hirotaka Okamoto; Naohiro Hosomura; Masami Asakawa; Katsuhiro Sano; Utaroh Motosugi; Tomoaki Ichikawa; Tadao Nakazawa; Hideki Fujii
Journal:  Surg Today       Date:  2013-07-05       Impact factor: 2.549

2.  Clinical evaluation of serum alpha-fetoprotein-IgM immune complexes on the diagnosis of primary hepatocellular carcinoma.

Authors:  Jiang Jingting; Wu Changping; Xu Ning; Zhu yibei; Wu Jun; Ji Mei; Xu Bin; Nilsson-Ehle Peter; Zhang Xueguan
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

Review 3.  Fibrolamellar carcinoma: 2012 update.

Authors:  Michael Torbenson
Journal:  Scientifica (Cairo)       Date:  2012-09-23

Review 4.  Fibrolamellar hepatocellular carcinoma: current clinical perspectives.

Authors:  Kelly J Lafaro; Timothy M Pawlik
Journal:  J Hepatocell Carcinoma       Date:  2015-10-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.